Menu
27/02/2012
Lilly To Invest €330m in New Facility In Cork
Minister for Jobs, Enterprise and Innovation Richard Bruton TD today announced that Eli Lilly and Company, a global leader in biopharmaceuticals, is to invest €330 million in a brand-new facility at its Kinsale campus in Cork.
The investment will expand the Kinsale site's existing biopharmaceutical mission with the establishment of an additional world-class commercialisation and manufacturing facility.
The new facility, when fully operational, will require up to 200 highly skilled employees. In addition, a further 300 construction jobs will be created on the site during building works. IDA Ireland worked closely with Lilly to attract this investment to Ireland.
The planned 240,000-square-foot biopharmaceutical commercialisation and manufacturing facility announced today will further enhance the company’s ability to bring treatments for illnesses such as cancer and diabetes to patients worldwide. This is the second large investment Lilly has made at its Kinsale site in recent years. In 2006, the company announced a €300 million investment in its first biopharmaceutical manufacturing and new-product commercialisation facility at its Kinsale campus, which came on-stream in 2010.
Speaking at the announcement, Minister Bruton said: "The Action Plan for Jobs, which the government published recently, outlined a range of measures which we will take in 2012 to target the high-end manufacturing and health/life sciences sectors for further growth and also to deepen and develop the impact of multinational companies in Ireland. Today's announcement—that this world-leading company is making a substantial investment in expanding its facility in Kinsale with the creation of up to 200 permanent jobs—shows what is possible in these areas."
Ed Canary, General Manager of the Kinsale site, said: "This investment is an endorsement of the Lilly Kinsale site's success in developing a biopharmaceutical business in recent years and demonstrates our ability to rise to that challenge. This is in no small part due to the site’s excellent performance record, the talent of the workforce, and the support from IDA Ireland.
"In the past five years, we have hired and trained some highly talented people and now have a technical talent base and capability in biopharmaceutical commercialisation and manufacturing that makes us a very attractive company for highly skilled people."
(CD/GK)
The investment will expand the Kinsale site's existing biopharmaceutical mission with the establishment of an additional world-class commercialisation and manufacturing facility.
The new facility, when fully operational, will require up to 200 highly skilled employees. In addition, a further 300 construction jobs will be created on the site during building works. IDA Ireland worked closely with Lilly to attract this investment to Ireland.
The planned 240,000-square-foot biopharmaceutical commercialisation and manufacturing facility announced today will further enhance the company’s ability to bring treatments for illnesses such as cancer and diabetes to patients worldwide. This is the second large investment Lilly has made at its Kinsale site in recent years. In 2006, the company announced a €300 million investment in its first biopharmaceutical manufacturing and new-product commercialisation facility at its Kinsale campus, which came on-stream in 2010.
Speaking at the announcement, Minister Bruton said: "The Action Plan for Jobs, which the government published recently, outlined a range of measures which we will take in 2012 to target the high-end manufacturing and health/life sciences sectors for further growth and also to deepen and develop the impact of multinational companies in Ireland. Today's announcement—that this world-leading company is making a substantial investment in expanding its facility in Kinsale with the creation of up to 200 permanent jobs—shows what is possible in these areas."
Ed Canary, General Manager of the Kinsale site, said: "This investment is an endorsement of the Lilly Kinsale site's success in developing a biopharmaceutical business in recent years and demonstrates our ability to rise to that challenge. This is in no small part due to the site’s excellent performance record, the talent of the workforce, and the support from IDA Ireland.
"In the past five years, we have hired and trained some highly talented people and now have a technical talent base and capability in biopharmaceutical commercialisation and manufacturing that makes us a very attractive company for highly skilled people."
(CD/GK)
Related Northern Ireland Recruitment News Stories
Click here for the latest headlines.
04 December 2006
Eli Lilly to invest €400m at existing site in Kinsale
Biopharmaceuticals company Eli Lilly has unveiled plans to invest up to €400 million in a multi phase program to establish a manufacturing facility at its existing site in Dunderrow, Kinsale, Co Cork. The investment, supported by IDA Ireland, is expected to create a total of 200 jobs over the next five years.
Eli Lilly to invest €400m at existing site in Kinsale
Biopharmaceuticals company Eli Lilly has unveiled plans to invest up to €400 million in a multi phase program to establish a manufacturing facility at its existing site in Dunderrow, Kinsale, Co Cork. The investment, supported by IDA Ireland, is expected to create a total of 200 jobs over the next five years.
11 April 2007
Gilead Sciences To Invest 60 Million Euro In New Biopharmaceutical Facility In Dublin
Irish Minister for Enterprise, Trade and Employment Micheál Martin announced that a leading international biopharmaceutical company, Gilead Sciences Limited, will invest 60 million euro in developing a new world-class pharmaceutical plant at Grange Castle Business Park, Clondalkin, Dublin.
Gilead Sciences To Invest 60 Million Euro In New Biopharmaceutical Facility In Dublin
Irish Minister for Enterprise, Trade and Employment Micheál Martin announced that a leading international biopharmaceutical company, Gilead Sciences Limited, will invest 60 million euro in developing a new world-class pharmaceutical plant at Grange Castle Business Park, Clondalkin, Dublin.
29 January 2008
Jobs Boost For Laois
Sixty new jobs are to be created at a major new Iarnrod Eireann Traincare maintenance facility in Co Laois. The National Traincare Maintenance facility, located on a 39 acre site to the west of Portlaoise town centre, will play a central role in the major improvements planned for Iarnród Éireann’s Intercity services.
Jobs Boost For Laois
Sixty new jobs are to be created at a major new Iarnrod Eireann Traincare maintenance facility in Co Laois. The National Traincare Maintenance facility, located on a 39 acre site to the west of Portlaoise town centre, will play a central role in the major improvements planned for Iarnród Éireann’s Intercity services.
12 February 2014
Roscommon Job Announcements Welcomed
Fine Gael TD for Roscommon/South Leitrim, Frank Feighan, has said that the 250 jobs announced for Roscommon in the last week by a number of global pharmaceutical companies are a massive vote of confidence in the county's infrastructure and its people.
Roscommon Job Announcements Welcomed
Fine Gael TD for Roscommon/South Leitrim, Frank Feighan, has said that the 250 jobs announced for Roscommon in the last week by a number of global pharmaceutical companies are a massive vote of confidence in the county's infrastructure and its people.
18 February 2011
Jobs Boost As Foster 'Goes On The Bottle'
Ballymena is in line for new jobs this week with the NI Enterprise Minister Arlene Foster officially opening a £3.2m bottling plant in Ballymena.
Jobs Boost As Foster 'Goes On The Bottle'
Ballymena is in line for new jobs this week with the NI Enterprise Minister Arlene Foster officially opening a £3.2m bottling plant in Ballymena.
-
Northern Ireland WeatherToday:A showery start with outbreaks most frequent north of Lough Neagh and through the morning, before dwindling during the afternoon as the northwest breezes ease and brighter spells of weak sunshine prosper. Maximum temperature 8 °C.Tonight:A dry night, save for a few light showers around the coasts, with prolonged clear spells and light winds bringing a frosty dawn for many in central and southern parts. Minimum temperature -3 °C.
